Additional file 4: of HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy

Figure S2. Evaluation of CD133 marker on Saos2 and MG63 cell lines after VPA and DAC treatment. Flow cytometric analyses showed a strong increase of CD133 expression after drug treatments. ** p < 0.001, *** p < 0.0001 compared to the untreated cells. (TIF 242 kb)